Announcements & Publications

News

November 17, 2020
Goldilocks Therapeutics presents at the (virtually held) Life Sciences Summit 2020.
To access the 7-minute video, please click on the “play” icon below.

September 25, 2020
Efficacy data on the use of an MNP version of a renalase agonist peptide in treating cisplatin-induced chronic kidney disease in mice presented at the New York Academy of Sciences “Drug Discovery for Remission of Chronic Kidney Disease” conference

September 17, 2020
Research article published showing that MNP-encapsulated NEMO binding peptide decreases ischemic acute kidney injury in a mouse model

June 23, 2020
Mesoscale nanoparticle technology shown to be effective in a mouse model of ischemic acute kidney injury

February 10, 2020
Goldilocks CEO Arthur Klausner interviewed at the BIO CEO conference in New York City

Presentations

Goldilocks CEO Arthur Klausner presented at the BIO CEO conference in New York City on February 12, 2020. The slide deck can be found here.

Scientific Articles

Renal Proximal Tubular NEMO Plays a Critical Role in Ischemic Acute Kidney Injury (2020)

Selective Nanoparticle-Mediated Targeting of Renal Tubular Toll-Like Receptor 9 Attenuates Ischemic Acute Kidney Injury (2020)

Edaravone-Loaded Mesoscale Nanoparticles Treat Cisplatin-Induced Acute Kidney Injury (2020)

Selective Nanoparticle Targeting of the Renal Tubules (2018)

Mesoscale Nanoparticles – An Unexpected Means for Selective Therapeutic Targeting of Kidney Diseases! (2018)

Nanomedicines for Kidney Diseases (2016)

Mesoscale Nanoparticles Selectively Target the Renal Proximal Tubule Epithelium (2015)

Posters

Peritubular Transcytosis Enables Mesoscale Nanoparticle Treatment of Acute Kidney Injury (2020 American Society of Nephrology Annual Meeting)

Mesoscale Nanoparticles Treat Cisplatin-Induced Acute Kidney Injury and Avoid Tumor Accumulation (2019 American Society of Nephrology Annual Meeting)

Treatment of Cisplatin-Induced Acute Kidney Injury with Renal Selective Nanotherapy (2018 American Society of Nephrology Annual Meeting)

Treatment of Acute Kidney Injury with Kidney Targeting Mesoscale Nanoparticles (2018 Annual Meeting of the Controlled Release Society)

Renal Selective Mesoscale Nanoparticles Treat Cisplatin-Induced Acute Kidney Injury (2017 American Society of Nephrology Annual Meeting)

Mesoscale Nanoparticles Selectively and Safely Target the Renal Proximal Tubules (2017 American Society of Nephrology Annual Meeting)

Renal Selective Mesoscale Nanoparticles Treat Cisplatin-Induced Acute Kidney Injury (2017 American Society of Nephrology Annual Meeting)